Thursday, February 17, 2022
This transmittal provides notice of coverage and reimbursement for the antiviral drug therapy, remdesivir, in the professional fee schedule for fee-for-service providers that bill HCPCS and CPT codes on CMS-1500 claim forms, and for providers enrolled in Medicaid Managed Care Organization (MCO) networks.